Research

Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.

A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.

Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).

The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.

Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.

Plans are underway to create ease of connection between UVA's Research Park, CHO, and the Hollymead Town Center to benefit Virginia visitors and businesses.

UVA Professor Ben Castleman is kickstarting a new, five-year strategic initiative to increase the number of students completing college and landing better-paying jobs in Virginia and beyond.

The University has approved an academic affiliation with INOVA Health System and George Mason University.

UVA researcher Jennifer Chiu and colleagues at the Curry School of Education are working on methods for integrating technology-enhanced engineering design projects and STEM curricula into early education with school systems in Virginia and beyond.

UVA Engineering is responding to a need for engineers trained to solve the complex, global problems of the 21st century.

The CvilleBioHub has been awarded over $80,000 from the GO Virginia initiative to expand and sustain the biotechnology ecosystem in the region.

UVA researchers propose that the business community can address sustainability challenges through innovation and development of new technologies.